How have WILLF shares performed in 2024?

Demant A/S's stock was trading at $44.00 on January 1st, 2024. Since then, WILLF stock has increased by 7.6% and is now trading at $47.33. View the best growth stocks for 2024 here .

Are investors shorting Demant A/S?

Demant A/S saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 691,700 shares, a drop of 20.9% from the April 30th total of 875,000 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently 1,383.4 days. View Demant A/S's Short Interest .

How do I buy shares of Demant A/S?

Shares of WILLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:WILLF

Demant A/S (WILLF) Stock Price, News & Analysis

→ Trump conviction scandal exposed (From Porter & Company) (Ad)

Free WILLF Stock Alerts

$47.33

0.00 (0.00%)

(As of 05/31/2024 ET)

Compare

Today's Range: $47.33
▼
$47.33
50-Day Range: $45.88
▼
$51.49
52-Week Range: $37.40
▼
$54.00

Volume: 166 shs
Average Volume: 588 shs
Market Capitalization: N/A

P/E Ratio: 2.05
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get Demant A/S alerts:

Ad Weiss Ratings

On June 10, Nvidia makes its next big move

A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”

Click here to find out who they are.

About Demant A/S Stock (OTCMKTS:WILLF)

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

WILLF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

WILLF Stock News Headlines

June 1 at 2:26 AM | americanbankingnews.com

Demant A/S (OTCMKTS:WILLF) Short Interest Update

See More Headlines

Receive WILLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Demant A/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:WILLF
CUSIP: N/A
CIK: N/A
Web: www.demant.com
Phone: (453) 917-7300
Fax: N/A
Employees: 21,623
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 2.05
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Søren Nielsen (Age 54)
CEO, President & Member of Executive Board
Comp: $2.13M
Mr. René Schneider M.Sc (Age 51)
CFO & Member of Executive Board
Comp: $1.02M
Mr. Niels Wagner (Age 53)
President of Hearing Care & Member of Executive Board
Comp: $801.12k
Mr. Peter Pudselykke
Head of Investor Relations
Ms. Trine Kromann-Mikkelsen
Vice President of Corporate Communication and Sustainability
Mr. Finn Mohring (Age 59)
Senior Vice President of R&D

Key Competitors

View All Competitors

WILLF Stock Analysis - Frequently Asked Questions

How have WILLF shares performed in 2024?: Demant A/S's stock was trading at $44.00 on January 1st, 2024. Since then, WILLF stock has increased by 7.6% and is now trading at $47.33.
View the best growth stocks for 2024 here.
Are investors shorting Demant A/S?: Demant A/S saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 691,700 shares, a drop of 20.9% from the April 30th total of 875,000 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently 1,383.4 days.
View Demant A/S's Short Interest.
How do I buy shares of Demant A/S?: Shares of WILLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:WILLF) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial